ArticleTrials2026

Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial.

Xin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.